Pediatrix Medical Group, Inc. (New York Stock Exchange:MD)
| Market Cap | 2.12B+50.8% |
| Revenue (ttm) | 1.95B+0.5% |
| Net Income | 174.81M+59.0% |
| EPS | 2.09+64.6% |
| Shares Out | 82.12M |
| PE Ratio | 12.10 |
| Forward PE | 10.58 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 54,437 |
| Open | 25.54 |
| Previous Close | 25.83 |
| Day's Range | 25.54 - 25.98 |
| 52-Week Range | 15.70 - 27.94 |
| Beta | 0.61 |
| Analysts | Hold |
| Price Target | 26.60(+2.96%) |
| Earnings Date | Nov 2, 2026 |
Insiders here have filed 8 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About MD
Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix provides comprehensive maternal-fetal medicine services in both clinical and inpatient settings, involving specialists such as maternal-fetal medicine physicians, obstetricians, and genetic counselors. Furthermore, the group delivers pediatric cardiology services, addressing both congenital and acquired heart conditions in patients ranging from the fetal stage through adulthood, under the care of dedicated pediatric cardiologists. Beyond these core areas, Pediatrix extends its expertise to various other pediatric subspecialties, including those requiring intensivists, surgeons, and ophthalmologists, and supplies vital support to hospital departments like emergency rooms and labor and delivery units. Established in 1979 in Sunrise, Florida, and formerly known as MEDNAX, Inc. until its renaming in July 2022, the company managed a network of approximately 2,700 physicians as of February 2022.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$MD stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in MD holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by MD's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
MD Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New MD patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to MD from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in MD
| ETF | Est. Holding Size |
|---|---|
| IJRiShares Core S&P Small-Cap ETF | $122.47M |
| VTIVanguard Morningstar Total Stock Market ETF | $68.84M |
| IWMiShares Russell 2000 ETF | $55.92M |
| VBVanguard Morningstar Small-Cap ETF | $49.49M |
| VBRVanguard Morningstar Small-Cap Value ETF | $31.48M |
| DFATDimensional - US Targeted Value ETF | $29.42M |
Estimated from each fund’s disclosed top holdings × AUM
MD Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from MD’s recent data — informational, not investment advice
